Your browser doesn't support javascript.
loading
Synthesis and anti-inflammatory activities of two new N-acetyl glucosamine derivatives.
Zhang, Zhichang; Wang, Weicheng; Xu, Peng; Cui, Quanjun; Yang, Xinlin; Hassan, Ameer E.
Affiliation
  • Zhang Z; Department of Orthopaedic Surgery, School of Medicine, University of Virginia, 450 Ray C. Hunt Drive, Charlottesville, VA, 22903, USA.
  • Wang W; Department of Orthopaedic Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, Henan, China.
  • Xu P; Department of Orthopaedic Surgery, School of Medicine, University of Virginia, 450 Ray C. Hunt Drive, Charlottesville, VA, 22903, USA.
  • Cui Q; Department of Pathology, University of Virginia, Charlottesville, 22903, USA.
  • Yang X; Department of Orthopaedic Surgery, School of Medicine, University of Virginia, 450 Ray C. Hunt Drive, Charlottesville, VA, 22903, USA.
  • Hassan AE; Department of Orthopaedic Surgery, School of Medicine, University of Virginia, 450 Ray C. Hunt Drive, Charlottesville, VA, 22903, USA. xy3c@virginia.edu.
Sci Rep ; 14(1): 11079, 2024 05 14.
Article in En | MEDLINE | ID: mdl-38745047
ABSTRACT
N-acetyl glucosamine (NAG) is a natural amino sugar found in various human tissues with previously described anti-inflammatory effects. Various chemical modifications of NAG have been made to promote its biomedical applications. In this study, we synthesized two bi-deoxygenated NAG, BNAG1 and BNAG2 and investigated their anti-inflammatory properties, using an in vivo and in vitro inflammation mouse model induced by lipopolysaccharide (LPS). Among the parent molecule NAG, BNAG1 and BNAG2, BNAG1 showed the highest inhibition against serum levels of IL-6 and TNF α and the leukocyte migration to lungs and peritoneal cavity in LPS challenged mice, as well as IL-6 and TNF α production in LPS-stimulated primary peritoneal macrophages. BNAG2 displayed an anti-inflammatory effect which was comparable to NAG. These findings implied potential application of these novel NAG derivatives, especially BNAG1, in treatment of certain inflammation-related diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylglucosamine / Lipopolysaccharides / Tumor Necrosis Factor-alpha / Macrophages, Peritoneal / Anti-Inflammatory Agents Limits: Animals Language: En Journal: Sci Rep Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylglucosamine / Lipopolysaccharides / Tumor Necrosis Factor-alpha / Macrophages, Peritoneal / Anti-Inflammatory Agents Limits: Animals Language: En Journal: Sci Rep Year: 2024 Document type: Article